Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1473-1477

  Masuda, Hidetaka ^a   Tanaka, Toshiko ^a   Matsushima, Shoko ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Active oxygen radicals; Cisplatin; Human ovarian cancer cell line; Hyperthermia

Indexed keywords

CISPLATIN; DNA; LUCIFERIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL CULTURE; CELL FREE SYSTEM; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HYPERTHERMIC THERAPY; OVARY CANCER; PRIORITY JOURNAL;

CELL LINE; CELL SURVIVAL; CELL-FREE SYSTEM; CHEMILUMINESCENT MEASUREMENTS; CISPLATIN; DNA, NEOPLASM; FEMALE; FEVER; FREE RADICALS; HEAT; HUMANS; KINETICS; OVARIAN NEOPLASMS; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED;

EID: 0031858198     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Halliwell B and Gutteridge JMC: In: Free Radicals in Biology and Medicine (Halliwell B and Gutteridge JMC eds), Oxford, Clarendon Press, 1989, pp 416-494.
2. Sinha BK: Free radicals in anticancer drug pharmacology. Chem Biol Interact 69: 293-317, 1989.
3. Bienvenu P, Caron L, Gasparutto D and Kergonou JF: In: Free Radicals and Aging (Emerit I and Chance B, eds). Basel, Switzerland, Birkhauser Verlag, 1992, pp 257-265.
4. Masuda H, Tanaka T and Takahama U: Cisplatin generates Superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203: 1175-1180, 1994.
5. Wallner KE, DeGregorio MW and Li GC: Hyperthermic potentiation of cis-diammine-dichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242-6245, 1986.
6. Kusumoto T, Holden SA, Ara G and Teicher BA: Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo. Int J Hyperthermia 11: 575-586, 1995.
7. Hettinga JV, Lemstra W, De Vries EG, Konings AW and Kampinga HH: Sensitization to cisplatin action by step-down heating in cDDP-sensitive and -resistant cells. Int J Cancer 61: 722-726, 1995.
8. Raaphorst GP, Chabot P, Doja S, Wilkins D, Stewart D and Ng CE: Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hyperthermia 12: 211-222, 1996.
9. Raaphorst GP, Doja S, Davis L, Stewart D and Ng CE: A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cells sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 37: 574-580, 1996.
10. Beketic-Oreskovic L, Jaksic M, Oreskovic S and Osmak M: Hyperthermic modulation of resistance to cis-diamminedichlo-roplatinum(II) in human larynx carinoma cells. Int J Hyperthermia 13: 205-214, 1997.
11. Hettinga JVE, Lemstra W, Meijer C, Dam WA, Uges DRA, Konings AWT, De Vries EGE and Kampinga HH: Mechanism of hyperhtermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. Br J Cancer 75: 1735-1743, 1997.
12. Otsubo T, Saito H, Tanaka N, Tsuzuki H, Saito T and Kano E: In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 43: 43-50, 1997.
13. Leopold KA, Oleson JR, Clarke-Pearson D, Soper J, Berchuck A, Samulski TV, Page RL, Blivin J, Tomberlin JK and Dewhirst MW: Intiaperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys 27: 1245-1251, 1993
14. Sugimachi K, Kuwano H, Ide H, Toge T, Saku M and Oshiumi Y: Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randamizedtrial. Int J Hyperthermia 10: 485-493, 1994
15. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y and Sasaki T: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119: 437-444, 1996.
16. Ohno S, Siddik ZH, Kido Y, Zwelling LA and Bull JMC: Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol 34: 302-306,1994.
17. Miyahara T, Ueda K, Akaboshi M, Shimada Y, Imamura M and Utsumi H: Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum(II) in cultured human esophageal cancer cells. Jpn J Cancer 84: 336-340, 1993.
18. Akaboshi M, Tanaka Y, Kawai K, Akuta K, Masunaga S and Ono K: Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195m-radio-labelled cis-diamminedichloroplatinum(II). Int J Radiat Biol 66: 215-220, 1994.
19. Masuda H, Tanaka T, Kido A, Kitamura and Kusaba I: Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer J 4: 283-288, 1991.
20. Meyn RE, Corry PM, Fletcher SE and Demetriades M: Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 40: 1136-1139, 1980.
21. Barlogie B, Corry PM and Drewinko B: In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res 40: 1165-1168, 1980.
22. Masuda H, Tanaka T, Matsuda H and Kusaba I: Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 50: 1863-1866, 1990.
23. Masuda H, Tanaka T, Kido A and Kusaba I: Potentiation of cisplatin against sensitive and resistant human ovarian cancer cell lines by amphotericin B. Cancer J 4: 119-124, 1991.
24. Benchekroun MN, Myers CE and Sinha BK: Free radical formation by ansamycin benzoquinone in human breast tumor cells: implications for cytotoxicity and resistance. Free Radical Biol Med 17: 191-200, 1994.
25. Corry PM, Robinson S and Getz S: Hyperthermia effects on DNA repair mechanisms. Radiology 123: 475-482, 1977.
26. Meyn RE, Corry PM and Fletcher SE: Thermal enhancement of DNA strand breakage in mammalian cells treated with bleomycin. Int J Radiat Oncol Biol Phys 5: 1487-1489, 1979.
27. Herman TS, Teicher BA, Cathcart KNS, Kaufman ME, Lee JB and Lee MH: Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123) 2[tetra-chloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Res 48: 5101-5105, 1988.
28. Yano T, Nakatani K, Nakano H, Ihara M and Ohnishi T: Hyperthermic enhancement of cis-diamminedichloroplatinum(II)-induced DNA damage in human esophageal cancer transplantable to nude mice. Anticancer Res 13: 1989-1998, 1993.
29. Sugihara K, Nakano K, Koda M, Tanaka K, Fukuishi N and Gemba M: Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 43: 247-252, 1987.
30. Sugihara K, Nakano S and Gemba M: Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 44: 71-76, 1987.
31. McGinness JE, Proctor PH, Demopoulos HB, Hokanson JA and Kirkpatrick DS: Amelioration of cis-platinum nephrotoxicity by orgotein superoxide dismutase. Physiol Chem Phys 10: 267-277, 1978.
32. Dobyan DC, Bull JM, Strebel FR, Sunderland BA and Bulger RE: Protective effects of [o-(ß-Hydroxyethyl)-rutoside] on cis-platinum-induced acute renal failure in the rat. Lab Invest 55: 557-563, 1986.
33. Sugihara K and Gemba M: Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 40: 353-355, 1986.
34. Bull JM, Strebel FR, Sunderland BA, Bulger RE, Edwards M, Siddik ZH and Newman A: o-(ß-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment. Cancer Res 48: 2239-2244, 1988.